Patents by Inventor Sam Poon Ang

Sam Poon Ang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING INTESTINAL GLUTAMINE SYNTHETASE ACTIVITY DEFICIENCY
    Publication number: 20200110093
    Abstract: The present invention relates to a method for monitoring intestinal glutamine synthetase levels in a mammal, particularly in a human subject, and is useful for detecting intestinal glutamine synthetase deficiency. The method is based on determining glutamate levels in the subject under controlled fasting and postprandial conditions after administration of a predetermined quantity of a glutamate containing protein composition. The method is useful for quantifying the ability of the mammal to metabolize dietary glutamate as a diagnostic marker for predicting the onset of or propensity for developing a central nervous system (CNS), psychotic, or neurological disorder, associated with glutamate toxicity. The method is also useful for designing regimens for rectifying glutamine synthetase deficiency levels in a mammal subject in order to treat or prevent such a disorder.
    Type: Application
    Filed: December 2, 2019
    Publication date: April 9, 2020
    Inventors: Victoria Jung-Pan LIANG, Jocelyn ShinWei ANG, Andrew Celino GACUYA, Sam Poon ANG
  • METHOD FOR MONITORING GLUTAMINE SYNTHETASE LEVELS
    Publication number: 20190162732
    Abstract: The present invention relates to a method for monitoring intestinal glutamine synthetase levels in a mammal, particularly in a human subject, and is useful for detecting intestinal glutamine synthetase deficiency. The method is based on determining glutamate levels in the subject under controlled fasting and postprandial conditions after administration of a predetermined quantity of a glutamate containing protein composition. The method is useful for quantifying the ability of the mammal to metabolize dietary glutamate as a diagnostic marker for predicting the onset of or propensity for developing a central nervous system (CNS), psychotic, or neurological disorder, associated with glutamate toxicity. The method is also useful for designing regimens for rectifying glutamine synthetase deficiency levels in a mammal subject in order to treat or prevent such a disorder.
    Type: Application
    Filed: December 18, 2018
    Publication date: May 30, 2019
    Inventors: Victoria Jung-Pan LIANG, Jocelyn ShinWei ANG, Andrew Celino GACUYA, Sam Poon ANG
  • Compositions For Treating Chronic Viral Infections
    Publication number: 20120082719
    Abstract: The present invention describes dietary compositions and methods of using such compositions to treat chronic viral infections, including hepatitis B and hepatitis C infections.
    Type: Application
    Filed: October 5, 2010
    Publication date: April 5, 2012
    Inventor: Sam Poon Ang
  • Compositions For Treating Chronic Viral Infections
    Publication number: 20120082720
    Abstract: The present invention describes dietary compositions and methods of using such compositions to treat chronic viral infections, including hepatitis B and hepatitis C infections.
    Type: Application
    Filed: January 11, 2011
    Publication date: April 5, 2012
    Inventor: Sam Poon Ang